Drawing for REPOXYGEN

USPTO serial 78430797

REPOXYGEN

Reviewed by CopyMark Law Group

Reg. 3182505Status 710
Filing date
Status date
Registration date
Dec 12, 2006
Examiner
FERRAIUOLO, DOMINIC
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with REPOXYGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Purvi J. Patel

Purvi J. Patel Haynes and Boone, LLP2323 Victory Avenue, Suite 700Dallas, TX 75219-7673UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical products for use in industry and science; enzymes; chemical products for in-vitro use in laboratories and for analysis; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles, namely chemical products for use in biotechnology, research and development and recombinant deoxyribonucleic acid variations thereof, all for in-vivo useSECTION 8 - CANCELLED—
005Gene therapy and prophylaxis products, pharmaceutical substances and preparations, and chemical products for use in medical science, all for haematological disorders; vaccines, enzymes and enzyme preparations, pharmaceuticals for the delivery of erythropoietin genes to muscle cells, all for medical purposes; hypoxia response pharmaceutical substances and preparations, viral and retroviral vectors, viral and retroviral vector manufacturing preparations; pharmaceutical and biochemical preparations for the treatment of anaemiaSECTION 8 - CANCELLED—
010Instruments and apparatus for the administration of gene therapy and prophylaxis preparations and substances, pre-filled vials; syringes and injectors for medical purposesSECTION 8 - CANCELLED—
042Scientific and medical research and development; genetic engineering services, biotechnology services, licensing of intellectual property, advisory services relating to gene therapy productsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 19, 2013C8..CANCELLED SEC. 8 (6-YR)—
Dec 17, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 17, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 12, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 26, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 6, 2006NPUBNOTICE OF PUBLICATION—
Jul 31, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 28, 2006ALIEASSIGNED TO LIE—
Jul 25, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 25, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 23, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 23, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 2, 2006CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 1, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Aug 17, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 17, 2005FAXXFAX RECEIVED—
Jul 14, 2005CNSIINQUIRY AS TO SUSPENSION MAILED—
Jul 13, 2005CNSISUSPENSION INQUIRY WRITTEN—
Jul 11, 2005RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 10, 2005CNSLLETTER OF SUSPENSION MAILED—
Jan 8, 2005CNSLSUSPENSION LETTER WRITTEN—
Jan 7, 2005DOCKASSIGNED TO EXAMINER—
Jun 14, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance